Nirmatrelvir–Ritonavir and Viral Load Rebound in Covid-19

por Anderson, Annaliesa S., Caubel, Patrick, Rusnak, James M.
Publicado 2022

532. Nirmatrelvir/Ritonavir Versus Placebo in Unvaccinated and Vaccinated High Risk Patients

por Leister-Tebbe, Heidi, Bao, Weihang, Fountaine, Robert, Baniecki, Mary Lynn, Hendrick, Victoria, Wisemandle, Wayne, Hammond, Jennifer, Rusnak, James
Publicado 2023

786. Effect of Nirmatrelvir/Ritonavir versus Placebo on COVID-19─Related Hospitalizations and Other Medical Visits

por Hammond, Jennifer, Leister-Tebbe, Heidi, Gardner, Annie, Abreu, Paula, Bao, Weihang, Wisemandle, Wayne, Ansari, Wajeeha, Simón Campos, Jesus Abraham, Pypstra, Rienk, Rusnak, James M
Publicado 2022

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

por Hammond, Jennifer, Leister-Tebbe, Heidi, Gardner, Annie, Abreu, Paula, Bao, Weihang, Wisemandle, Wayne, Baniecki, MaryLynn, Hendrick, Victoria M., Damle, Bharat, Simón-Campos, Abraham, Pypstra, Rienk, Rusnak, James M.
Publicado 2022